Tiamulin fumarat – new makrolide on bovine mastitis therapy in vivo and in vitro
Kriukova Vera, Kuznechova Nadezda, Gaponova Viktoriya and 1 more
BIO Web of Conferences · 2020
doi:10.1051/bioconf/20201700203 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Antibiotics nowadays are widely used for the treatment of mastitis in cows, which, along with a positive effect, cause negative consequences to the organism of an animal, can be consumed by people and interacts the cultural qualities of microorganisms However, it is almost impossible to refuse from antibacterial therapy of mastitis with chemotherapy drugs. And the variety range of chemotherapy drugs for mastitis therapy today is very wide. Since we conduct monitoring devoted to full characteristics of the strains of Streptococcus spp., isolated from bovine mastitis milk of the geographical zone of Leningrad region, Russia. That is, we analyses received data on the cultural, microbiological, serological, virulence factors, and sensibility to main used in practice antibiotics and to new ones. Taking into account the already proven resistance of microorganisms to antibiotics, the biological industry offers antibacterial drugs based on new active substances for use in the treatment of cow mastitis. In the assay described in this paper, we set a goal-to investigate the antibacterial effect of tiamulin fumarat to clinical isolates of streptococci received from milk of cows with mastitis, and to determine its clinical efficacy on cows with mastitis of the bacteriological etiology
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.